The Long Read: Innovation, Access & Affordability in the USA
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly all R&D indices related to…
Tagged with Glenmark
Mexico Looks to India to Bolster Domestic Supply Chain post-COVID
COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in Mexico where the state of Hidalgo has…
US Generics: Company Culture Key to Attracting Talent
Two leading executives in the US generics market outline why robust company culture is key to attracting top talent that might otherwise gravitate…
Hot Topics in US Healthcare & Pharma
So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…
Robert Matsuk – President, Glenmark North America
Robert Matsuk, president of Glenmark North America, introduces the scope of the company’s operations in the US – including a manufacturing…
Interview: Kurt Stoeckli – Managing Director, Glenmark…
The Chief Scientific Officer and President of Glenmark Pharmaceuticals Swiss R&D Center elaborates on Glenmark’s endeavor to venture up the…
Interview: Maria Bella Aranas – Country Manager, Glenmark…
Maria Bella Aranas, Country Manager of Glenmark Philippines, discusses the affiliates growing product portfolio in the country and their plans to…
Glenmark Argentina – Carlos Grzelak, Country Manager
Glenmark’s country manager for Argentina discusses Argentina’s development expertise and how companies like Glenmark can capitalize on it…
Interview: Glenn Saldanha, Managing Director & CEO, Glenmark
Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully…
